Clinical Research

Filters

Guide to Post-Market Clinical Follow-up Requirements Under EU MDR (2017/745)

Published: March 18, 2025

View

Video: Why Should You Advocate for Yourself with the FDA?

View

Video: What are the 4 Types of FDA Q-Submissions?

View

Video: What Happens When Your Lead Reviewer or Team Changes?

View

Video: Pre-Submission Meetings-Should You Talk to the FDA or Not? | Part 2

View

Video: Pre-Submission Meetings-Should You Talk to the FDA or Not? | Part 1

View

Video: How Do You De-Risk Your Trial to Save Time?

View

Video: What are the Stages of Clinical Trials?

View

Video: What is the FDA’s Thoughts on Physician Experiential Data?

View

Video: What is the FDA’s Appetite for Non-Traditional Trial Design? | Part 2

View

Video: What is the FDA’s Appetite for Non-Traditional Trial Design? | Part 1

View

Video: What’s the Difference Between a Randomized Study vs. Single Arm Performance Goal?

View

Video: Have You Argued Your Statistics with the FDA?

View

Video: Are There Tracks Similar to Breakthrough for Fast-Tracking Payments from CMS?

View

Video: What is the Average Timeframe to Get CMS Coverage?

View

Video: What is the Average Time to Gain Regulatory Authorization?

View

Let’s Talk About Your Project

Ask a question or request a meeting with a NAMSA expert to discuss your specific project. We will follow up as quickly as possible. Also, please tell us how you heard about NAMSA.

First Name*

Last Name/Surname*

Business Email*

Job Title*

Company*

Company Size*

Where Are You Based?*

Location of Company Office You Work At/Report To*

How can we help?

By choosing to submit your information to contact NAMSA, you are providing NAMSA consent to process and store your information on the NAMSA Network. At any time, you can submit a request to withdraw your consent for the use of information provided by you. For additional information, please visit our Privacy Policy.